HuGE Literature Finder
Records
1
-
15
| [Analysis of Gene Mutation Characteristics and Prognosis of Elderly Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2022 Jun 30 (3): 755-759. Zhou Nai-Cen, Li Guo-Hui, Qin Wei-Wei, Wang Wen-Qing, Guo Huai-Peng, Liu Cong, Liu |
| Clinicopathologic Characterization of Hypocellular Acute Myeloid Leukemia (AML) Showed Fewer Genetic Abnormalities Involving Cell Proliferation and NPM1 When Compared With Nonhypocellular AML. American journal of clinical pathology 2020 Oct . Carlsen Eric, Bailey Nathanael G, Aggarwal Nidhi, Illar Gwendolyn M, Wild Matthew, Yatsenko Svetlana A, Rea Bryan, Liu Yen-Ch |
| [Analysis of ASXL1 gene variant in patients with myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020 Feb 37 (2): 110-115. Chen Meiyu, Liu Jie, Chao Hongying, Qin Wei, Jiang Naike, Lu Xuzhang, Cen Ling, Jiang Yu, Cai Xiaohui, Zhang Ri, Wang Qi |
| [Analysis of RUNX1 Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Feb 28 (1): 202-208. Cai Xiao-Hui, Chen Mei-Yu, Chao Hong-Ying, Jiang Nai-Ke, Lu Xu-Zhang, Han Wen-Min, Qin Wei, Jia Zhu-X |
| The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes. British journal of haematology 2016 Mar . Olsson Linda, Zettermark Sofia, Biloglav Andrea, Castor Anders, Behrendtz Mikael, Forestier Erik, Paulsson Kajsa, Johansson Bert |
| IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association. Oncotarget 2015 Oct . Debarri Houria, Lebon Delphine, Roumier Christophe, Cheok Meyling, Marceau-Renaut Alice, Nibourel Olivier, Geffroy Sandrine, Helevaut Nathalie, Rousselot Philippe, Gruson Bérengère, Gardin Claude, Chretien Marie-Lorraine, Sebda Shéhérazade, Figeac Martin, Berthon Céline, Quesnel Bruno, Boissel Nicolas, Castaigne Sylvie, Dombret Hervé, Renneville Aline, Preudhomme Clau |
| Persistence of DNMT3A mutations at long-term remission in adult patients with AML. British journal of haematology 2014 Nov 167 (4): 478-86. Pløen Gro G, Nederby Line, Guldberg Per, Hansen Maria, Ebbesen Lene H, Jensen Uffe Birk, Hokland Peter, Aggerholm An |
| SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemia. Clinical biochemistry 2013 Feb . Yang J, Qian J, Yao DM, Qian SX, Qian W, Lin J, Xiao GF, Wang CZ, Deng ZQ, Ma JC, Chen XX |
| FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia. American journal of clinical pathology 2011 Jan 135 (1): 62-9. Bains Ashish, Luthra Rajyalakshmi, Medeiros L Jeffrey, Zuo Zhua |
| Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission. Blood 2010 Aug 116 (7): 1132-5. Nibourel Olivier, Kosmider Olivier, Cheok Meyling, Boissel Nicolas, Renneville Aline, Philippe Nathalie, Dombret Hervé, Dreyfus François, Quesnel Bruno, Geffroy Sandrine, Quentin Samuel, Roche-Lestienne Catherine, Cayuela Jean-Michel, Roumier Christophe, Fenaux Pierre, Vainchenker William, Bernard Olivier A, Soulier Jean, Fontenay Michaëla, Preudhomme Clau |
| The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. Blood 2010 Feb 115 (5): 948-56. Burnett Alan K, Hills Robert K, Green Claire, Jenkinson Sarah, Koo Kenneth, Patel Yashma, Guy Carol, Gilkes Amanda, Milligan Donald W, Goldstone Anthony H, Prentice Archibald G, Wheatley Keith, Linch David C, Gale Rosemary |
| AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood 2009 Dec 114 (26): 5352-61. Tang Jih-Luh, Hou Hsin-An, Chen Chien-Yuan, Liu Chieh-Yu, Chou Wen-Chien, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Lin Liang-In, Tien Hwei-Fa |
| Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis. Cancer 2009 Oct 115 (20): 4737-44. Konoplev Sergej, Huang Xuelin, Drabkin Harry A, Koeppen Hartmut, Jones Dan, Kantarjian Hagop M, Garcia-Manero Guillermo, Chen Weina, Medeiros L Jeffrey, Bueso-Ramos Carlos |
| NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS). Blood 2009 May 113 (21): 5250-3. Schneider Friederike, Hoster Eva, Unterhalt Michael, Schneider Stephanie, Dufour Annika, Benthaus Tobias, Mellert Gudrun, Zellmeier Evelin, Bohlander Stefan K, Feuring-Buske Michaela, Buske Christian, Braess Jan, Fritsch Susanne, Heinecke Achim, Sauerland Maria C, Berdel Wolfgang E, Buechner Thomas, Woermann Bernhard J, Hiddemann Wolfgang, Spiekermann Karst |
| DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome. Blood cells, molecules & diseases 0 53 (1-2): 61-6. El Ghannam Doaa, Taalab Mona M, Ghazy Hayam F, Eneen Asmaa |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 06, 2022
- Content source: